Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants of Sustained Virological Response After Discontinuation of Long-term Nucleoside Analogue Therapy in Chronic Hepatitis B Patients

NCT02581033 is registered in ClinicalTrials.gov with St Vincent's Hospital Melbourne as lead sponsor.

NCT NCT02581033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02581033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants of Sustained Virological Response After Discontinuation of Long-term Nucleoside Analogue Therapy in Chronic Hepatitis B Patients
Lead sponsor
St Vincent's Hospital Melbourne
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2014
Completion date
May 31, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b.